Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 250

The DOI matches its Crossref record.

Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease

Schneider, Lon S., Farlow, Martin R., Henderson, Victor W., Pogoda, Janice M. · 1996 · Neurology

Abstract

OBJECTIVE: To examine whether estrogen replacement therapy (ERT) affects clinical and cognitive responses to tacrine in women with Alzheimer's disease (AD). DESIGN: A 30-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial of tacrine in which a subgroup of women were receiving ERT prior to randomization. PATIENTS: Women with mild to moderate-stage AD, at least 50 years of age, who were enrolled in the previously reported trial. INTERVENTIONS: Randomized assignment to placebo or to one of three ascending-dosage regimens of tacrine: maximum dosages of 80 mg/d, 120 mg/d or 160 mg/d. OUTCOME MEASURES: Alzheimer's Disease Assessment Scale-Cognitive Scale (ADASc), Clinician Interview-Based Impression of change (CIBI), Mini-Mental State Examination (MMSE), Caregiver's Impression of Change (CIC). RESULTS: Of 318 women with evaluable data 14.5% were receiving ERT. Women completing the trial taking ERT and tacrine improved more than women not receiving ERT who were randomly assigned to tacrine or to placebo as assessed by the ADASc (p < 0.01), the CIBI (p = 0.02), the CIC (p = 0.006), and the MMSE (p = 0.07). They improved significantly on the ADASc (p = 0.01) using an intent-to-treat analysis. CONCLUSIONS: Prior and continuing ERT may enhance response to tacrine in women with AD. Randomized trials are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.46.6.1580

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 250

Metadata

Authors
Schneider, L. S., Farlow, M. R., Henderson, V. W., & Pogoda, J. M.
Venue
Neurology
Published
1996-06
Volume
46
Issue
6
Pages
1580-1584
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2005994343
Cited by
250
References
0
FWCI
27.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. https://app.cochat.ai/papers/10.1212/wnl.46.6.1580
The paper
Schneider, L. S., Farlow, M. R., Henderson, V. W., & Pogoda, J. M. (1996). Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. https://doi.org/10.1212/wnl.46.6.1580

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.